RIA Intel›Advisers›New York›MERLIN BIOMED INVESTMENT ADVISORS, LLC

MERLIN BIOMED INVESTMENT ADVISORS, LLC

Advisory

NEW YORK, NY

Data as of Mar 23, 2007 · Source: SEC Form ADV

Total AUM

$155M

1-Year AUM Growth

-46.0%

3-Year CAGR

-22.9%

Employees

0

Assets Under Management

Total AUM$155M

Discretionary AUM$155M

Non-Discretionary AUM$0

Discretionary %100%

Total Clients—

Team

Total Employees0

Investment Advisers0

Employee Growth (1Y)—

Filing History

Total Filings on Record8

First FilingAug 8, 2001

Latest FilingMar 23, 2007

🔒 Full AUM trend chart and 8 historical filings spanning 6+ years

Registration

Status—

Registration Date—

SEC RegisteredYes

Exempt ReportingNo

⚡ Succession Risk Score

Our proprietary 5-pillar model analyzes founder tenure, ownership concentration, AUM dependency, and more to score transition risk.

📊 Peer Benchmarking

See how this firm ranks against peers nationally and by state across AUM growth, efficiency, team size, and 16 other metrics.

👥 Owners & Officers

View the complete ownership structure from SEC Schedule A/B filings, including control persons and their tenure.

🏦 Client Demographics

Detailed breakdown of client types including individuals, high-net-worth, institutions, pension plans, and charitable organizations.

Get the full picture on MERLIN BIOMED INVESTMENT ADVISORS, LLC

Succession risk scoring, peer benchmarking, ownership structure, private fund details, and 20+ years of filing history.